2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Endocrine
1
Conditions
Carcinoma, Hepatocellular
44
Neoplasm Metastasis
19
Liver Neoplasms
18
Colorectal Neoplasms
15
Cholangiocarcinoma
11
Pancreatic Neoplasms
9
Lung Neoplasms
9
Colonic Neoplasms
9
Breast Neoplasms
8
Carcinoma, Renal Cell
7
Carcinoma, Non-Small-Cell Lung
7
Barrett Esophagus
7
Thyroid Nodule
6
Recurrence
6
Rectal Neoplasms
6
Thyroid Neoplasms
5
Pain
4
Neoplasms
4
Kidney Neoplasms
4
Esophageal Neoplasms
4
Thyroid Cancer, Papillary
3
Prostatic Neoplasms
3
Leiomyoma
3
Biliary Tract Neoplasms
3
Bile Duct Neoplasms
3
Agnosia
3
Thyroid Diseases
2
Hyperaldosteronism
2
Hepatitis B
2
Gallbladder Neoplasms
2
Interventions
Radiofrequency Ablation
2
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Staining and Labeling
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Prednisone
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Observation
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Fosfomycin
1
Dexamethasone
1
Clozapine
1
Ciprofloxacin
1
Cidofovir
1
Cefepime
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Hyperaldosteronism
×
Radiofrequency Ablation
×
Clear all
NCT02756754
2026-05-04
ADERADHTA
University Hospital, Toulouse
Phase NA
Completed
31 enrolled
NCT02030587
2017-04-25
LARFA
Chinese University of Hong Kong
Phase NA
Unknown
36 enrolled